Literature DB >> 27959714

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.

Amit V Khera1, Connor A Emdin1, Isabel Drake1, Pradeep Natarajan1, Alexander G Bick1, Nancy R Cook1, Daniel I Chasman1, Usman Baber1, Roxana Mehran1, Daniel J Rader1, Valentin Fuster1, Eric Boerwinkle1, Olle Melander1, Marju Orho-Melander1, Paul M Ridker1, Sekar Kathiresan1.   

Abstract

BACKGROUND: Both genetic and lifestyle factors contribute to individual-level risk of coronary artery disease. The extent to which increased genetic risk can be offset by a healthy lifestyle is unknown.
METHODS: Using a polygenic score of DNA sequence polymorphisms, we quantified genetic risk for coronary artery disease in three prospective cohorts - 7814 participants in the Atherosclerosis Risk in Communities (ARIC) study, 21,222 in the Women's Genome Health Study (WGHS), and 22,389 in the Malmö Diet and Cancer Study (MDCS) - and in 4260 participants in the cross-sectional BioImage Study for whom genotype and covariate data were available. We also determined adherence to a healthy lifestyle among the participants using a scoring system consisting of four factors: no current smoking, no obesity, regular physical activity, and a healthy diet.
RESULTS: The relative risk of incident coronary events was 91% higher among participants at high genetic risk (top quintile of polygenic scores) than among those at low genetic risk (bottom quintile of polygenic scores) (hazard ratio, 1.91; 95% confidence interval [CI], 1.75 to 2.09). A favorable lifestyle (defined as at least three of the four healthy lifestyle factors) was associated with a substantially lower risk of coronary events than an unfavorable lifestyle (defined as no or only one healthy lifestyle factor), regardless of the genetic risk category. Among participants at high genetic risk, a favorable lifestyle was associated with a 46% lower relative risk of coronary events than an unfavorable lifestyle (hazard ratio, 0.54; 95% CI, 0.47 to 0.63). This finding corresponded to a reduction in the standardized 10-year incidence of coronary events from 10.7% for an unfavorable lifestyle to 5.1% for a favorable lifestyle in ARIC, from 4.6% to 2.0% in WGHS, and from 8.2% to 5.3% in MDCS. In the BioImage Study, a favorable lifestyle was associated with significantly less coronary-artery calcification within each genetic risk category.
CONCLUSIONS: Across four studies involving 55,685 participants, genetic and lifestyle factors were independently associated with susceptibility to coronary artery disease. Among participants at high genetic risk, a favorable lifestyle was associated with a nearly 50% lower relative risk of coronary artery disease than was an unfavorable lifestyle. (Funded by the National Institutes of Health and others.).

Entities:  

Mesh:

Year:  2016        PMID: 27959714      PMCID: PMC5338864          DOI: 10.1056/NEJMoa1605086

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  36 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  A common variant on chromosome 9p21 affects the risk of myocardial infarction.

Authors:  Anna Helgadottir; Gudmar Thorleifsson; Andrei Manolescu; Solveig Gretarsdottir; Thorarinn Blondal; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Asgeir Sigurdsson; Adam Baker; Arnar Palsson; Gisli Masson; Daniel F Gudbjartsson; Kristinn P Magnusson; Karl Andersen; Allan I Levey; Valgerdur M Backman; Sigurborg Matthiasdottir; Thorbjorg Jonsdottir; Stefan Palsson; Helga Einarsdottir; Steinunn Gunnarsdottir; Arnaldur Gylfason; Viola Vaccarino; W Craig Hooper; Muredach P Reilly; Christopher B Granger; Harland Austin; Daniel J Rader; Svati H Shah; Arshed A Quyyumi; Jeffrey R Gulcher; Gudmundur Thorgeirsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Science       Date:  2007-05-03       Impact factor: 47.728

3.  Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.

Authors:  Vanessa Xanthakis; Danielle M Enserro; Joanne M Murabito; Joseph F Polak; Kai C Wollert; James L Januzzi; Thomas J Wang; Geoffrey Tofler; Ramachandran S Vasan
Journal:  Circulation       Date:  2014-10-01       Impact factor: 29.690

4.  A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study.

Authors:  George Thanassoulis; Gina M Peloso; Michael J Pencina; Udo Hoffmann; Caroline S Fox; L Adrienne Cupples; Daniel Levy; Ralph B D'Agostino; Shih-Jen Hwang; Christopher J O'Donnell
Journal:  Circ Cardiovasc Genet       Date:  2012-01-10

5.  Primary prevention of coronary heart disease in women through diet and lifestyle.

Authors:  M J Stampfer; F B Hu; J E Manson; E B Rimm; W C Willett
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

6.  Association between a literature-based genetic risk score and cardiovascular events in women.

Authors:  Nina P Paynter; Daniel I Chasman; Guillaume Paré; Julie E Buring; Nancy R Cook; Joseph P Miletich; Paul M Ridker
Journal:  JAMA       Date:  2010-02-17       Impact factor: 56.272

7.  Genetic susceptibility to death from coronary heart disease in a study of twins.

Authors:  M E Marenberg; N Risch; L F Berkman; B Floderus; U de Faire
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

8.  The Malmo Diet and Cancer Study. Design and feasibility.

Authors:  G Berglund; S Elmstähl; L Janzon; S A Larsson
Journal:  J Intern Med       Date:  1993-01       Impact factor: 8.989

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.

Authors:  Majid Nikpay; Anuj Goel; Hong-Hee Won; Leanne M Hall; Christina Willenborg; Stavroula Kanoni; Danish Saleheen; Theodosios Kyriakou; Christopher P Nelson; Jemma C Hopewell; Thomas R Webb; Lingyao Zeng; Abbas Dehghan; Maris Alver; Sebastian M Armasu; Kirsi Auro; Andrew Bjonnes; Daniel I Chasman; Shufeng Chen; Ian Ford; Nora Franceschini; Christian Gieger; Christopher Grace; Stefan Gustafsson; Jie Huang; Shih-Jen Hwang; Yun Kyoung Kim; Marcus E Kleber; King Wai Lau; Xiangfeng Lu; Yingchang Lu; Leo-Pekka Lyytikäinen; Evelin Mihailov; Alanna C Morrison; Natalia Pervjakova; Liming Qu; Lynda M Rose; Elias Salfati; Richa Saxena; Markus Scholz; Albert V Smith; Emmi Tikkanen; Andre Uitterlinden; Xueli Yang; Weihua Zhang; Wei Zhao; Mariza de Andrade; Paul S de Vries; Natalie R van Zuydam; Sonia S Anand; Lars Bertram; Frank Beutner; George Dedoussis; Philippe Frossard; Dominique Gauguier; Alison H Goodall; Omri Gottesman; Marc Haber; Bok-Ghee Han; Jianfeng Huang; Shapour Jalilzadeh; Thorsten Kessler; Inke R König; Lars Lannfelt; Wolfgang Lieb; Lars Lind; Cecilia M Lindgren; Marja-Liisa Lokki; Patrik K Magnusson; Nadeem H Mallick; Narinder Mehra; Thomas Meitinger; Fazal-Ur-Rehman Memon; Andrew P Morris; Markku S Nieminen; Nancy L Pedersen; Annette Peters; Loukianos S Rallidis; Asif Rasheed; Maria Samuel; Svati H Shah; Juha Sinisalo; Kathleen E Stirrups; Stella Trompet; Laiyuan Wang; Khan S Zaman; Diego Ardissino; Eric Boerwinkle; Ingrid B Borecki; Erwin P Bottinger; Julie E Buring; John C Chambers; Rory Collins; L Adrienne Cupples; John Danesh; Ilja Demuth; Roberto Elosua; Stephen E Epstein; Tõnu Esko; Mary F Feitosa; Oscar H Franco; Maria Grazia Franzosi; Christopher B Granger; Dongfeng Gu; Vilmundur Gudnason; Alistair S Hall; Anders Hamsten; Tamara B Harris; Stanley L Hazen; Christian Hengstenberg; Albert Hofman; Erik Ingelsson; Carlos Iribarren; J Wouter Jukema; Pekka J Karhunen; Bong-Jo Kim; Jaspal S Kooner; Iftikhar J Kullo; Terho Lehtimäki; Ruth J F Loos; Olle Melander; Andres Metspalu; Winfried März; Colin N Palmer; Markus Perola; Thomas Quertermous; Daniel J Rader; Paul M Ridker; Samuli Ripatti; Robert Roberts; Veikko Salomaa; Dharambir K Sanghera; Stephen M Schwartz; Udo Seedorf; Alexandre F Stewart; David J Stott; Joachim Thiery; Pierre A Zalloua; Christopher J O'Donnell; Muredach P Reilly; Themistocles L Assimes; John R Thompson; Jeanette Erdmann; Robert Clarke; Hugh Watkins; Sekar Kathiresan; Ruth McPherson; Panos Deloukas; Heribert Schunkert; Nilesh J Samani; Martin Farrall
Journal:  Nat Genet       Date:  2015-09-07       Impact factor: 38.330

View more
  331 in total

Review 1.  Impact of Genes and Environment on Obesity and Cardiovascular Disease.

Authors:  Yoriko Heianza; Lu Qi
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

2.  Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).

Authors:  Sherry-Ann N Brown; Hayan Jouni; Tariq S Marroush; Iftikhar J Kullo
Journal:  Circ Cardiovasc Genet       Date:  2017-08

3.  Familial Hypercholesterolemia in a Healthy Elderly Population.

Authors:  Paul Lacaze; Robert Sebra; Moeen Riaz; Amanda J Hooper; Jane Tiller; Andrew Bakshi; Robyn L Woods; Andrew M Tonkin; Christopher M Reid; Anne M Murray; Stephen J Nicholls; Gerald F Watts; Eric Schadt; John J McNeil
Journal:  Circ Genom Precis Med       Date:  2020-06-10

Review 4.  Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.

Authors:  Krishna G Aragam; Pradeep Natarajan
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 5.  New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease.

Authors:  Julius L Katzmann; Ulrich Laufs
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 6.  Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights.

Authors:  Ricardo Stein; Filipe Ferrari; Fernando Scolari
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

7.  Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women.

Authors:  Natalie A Bello; Eliza C Miller; Kirsten Lawrence Cleary; Ronald Wapner
Journal:  Ann Intern Med       Date:  2019-10-15       Impact factor: 25.391

Review 8.  Emerging Role of Precision Medicine in Cardiovascular Disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

Review 9.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

10.  Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease.

Authors:  George Hindy; Krishna G Aragam; Kenney Ng; Mark Chaffin; Luca A Lotta; Aris Baras; Isabel Drake; Marju Orho-Melander; Olle Melander; Sekar Kathiresan; Amit V Khera
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-22       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.